AVE has made a breakthrough with a phase III insomnia trial for its soft gel cannabidiol to manage sleeplessness. ... Read ...
Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Investor Webinar to be held July 14, 2026 VANCOUVER, BC / ACCESS Newswire / July 7, 2026 / Marimaca Copper Corp. ("Marimaca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results